MMG’s HK$9bn Rights Issue

Herbert Smith Freehills advised MMG on rights issue. MMG Limited (01208.HK) successfully completed a HK$9 billion rights issue, marking one of the largest equity fundraising efforts...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Jenscare Scientific’s Hong Kong IPO

O’Melveny represented Jenscare Scientific Co., Ltd on the deal. Herbert Smith Freehills advised China International Capital Corporation and Citigroup. Jenscare Scientific Co., Ltd. (9877.HK) announced its...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Biocytogen Pharmaceuticals’ Listing on the Main Board of the Hong Kong Stock Exchange

Herbert Smith Freehills has advised Goldman Sachs and China International Capital Corporation as joint sponsors and underwriters. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced the company’s official listing...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here